FDA clears test for disease affecting military personnel

The FDA has cleared Idaho Technology's nucleic acid amplification test to diagnose the early stages of Q fever infections in overseas military personnel. Q fever is an emerging infectious disease among U.S. soldiers serving in Iraq and worldwide and can cause acute or chronic illness in humans, who usually acquire infections after contact with infected animals or exposure to contaminated environments. If diagnosed early, most people with Q fever fully recover after treatment with appropriate antibiotics. Failure to treat an infection can, however, result in serious chronic illness. FDA's release

Suggested Articles

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s sequel to its VC megafund.

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.